DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Vistaril is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in VISTARIL is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
A generic version of VISTARIL was approved as hydroxyzine hydrochloride by WOCKHARDT BIO AG on April 12th, 1982.
Summary for VISTARIL
|Finished Product Suppliers / Packagers:||3|
|Raw Ingredient (Bulk) Api Vendors:||64|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for VISTARIL|
|What excipients (inactive ingredients) are in VISTARIL?||VISTARIL excipients list|
|DailyMed Link:||VISTARIL at DailyMed|
Recent Clinical Trials for VISTARIL
Identify potential brand extensions & 505(b)(2) entrants
|University of Colorado, Denver||N/A|